MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Clinical trials for MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Race to find better treatment for High-Risk blood cancers
Disease control OngoingThis study is testing whether adding one of two other drugs (lenalidomide or vorinostat) to the standard chemotherapy drug azacitidine works better for people with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). The goal is to see which comb…
Matched conditions: MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC
-
New hope for tough leukemia: Triple-Drug attack enters early testing
Disease control TerminatedThis early-stage study is testing the safety and best dose of a new three-drug combination for adults with acute myeloid leukemia (AML) or related blood cancers that have come back or not responded to prior treatments. The goal is to see if adding the drug regorafenib to two exis…
Matched conditions: MYELODYSPLASTIC SYNDROME ACUTE MYELOID LEUKEMIA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC